Clinical-stage ophthalmic medical device company developing Quantitative Corneal Cross-Linking (qCXL™), a personalized, non-invasive approach to refractive vision correction
Clinical-stage ophthalmic medical device company developing Quantitative Corneal Cross-Linking (qCXL™), a personalized, non-invasive approach to refractive vision correction. Its CXLens® system uses patterned ultraviolet light and biomechanical control to strengthen and reshape the cornea; the device is investigational.